Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Esperion Therapeutis.Inc. buy Heureka

Esperion Therapeutis.Inc.
Start price
€52.34
13.01.20 / 50%
Target price
€110.00
10.02.20
Performance (%)
15.67%
End price
€60.54
10.02.20
Summary
This prediction ended on 10.02.20 with a price of €60.54. The BUY prediction by Heureka finished with a performance of 15.67%. Heureka has 50% into this prediction

Esperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.

AI-generated
Performance without dividends (%)
Name 1w 1m 1y 3y
Esperion Therapeutis.Inc. 0.000% 0.000% 57.643% 84.600%
iShares Core DAX® 0,44 % 5,90 % 8,05 % 65,58 %
iShares Nasdaq 100 1,06 % 0,92 % 28,47 % 90,18 %
iShares Nikkei 225® 1,77 % 1,23 % 47,57 % 84,99 %
iShares S&P 500 0,37 % 1,92 % 23,20 % 70,76 %

Comments by Heureka for this prediction

In the thread Esperion Therapeutis.Inc. diskutieren
Prediction Buy
Perf. (%) 15.67%
Target price 85.000
Change
Ends at 10.02.20

Buy mit Kursziel 85,0

Heureka 
0
Report Share
13.01.20
Prediction Buy
Perf. (%) 15.67%
Target price 110.000
Change
Ends at 10.02.20

Kursziel geändert auf 110,0

Heureka 
0
Report Share
15.01.20
In the thread Trading Esperion Therapeutis.Inc.
Prediction Buy
Perf. (%) 15.67%
Target price 110.000
Change
Ends at 10.02.20

Buy beendet

Heureka 
0
Report Share
10.02.20

Stopped prediction by Heureka for Esperion Therapeutis.Inc.

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€56.00
26.02.20
€62.00
09.03.20
-30.14%
09.03.20

Heureka 
26.02.20 50%